Psy217 - Incremental Quality-Adjusted Survival Analysis When No Head to Head Data Are Available: A Case Study of Midostaurin (Mido) Versus Standard of Care (Soc) in Patients With Advanced Systemic Mastocytosis (Asm)
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2791
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV